Ben Liu
3 Papers
Ben Liu is an academic researcher. The author has contributed to research in topics: Osteoarthritis & Medicine. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Astragaloside IV as a novel CXCR4 antagonist alleviates osteoarthritis in the knee of monosodium iodoacetate-induced rats.
Kuangyang Yang,Qian Xie,Tingting Tang,Na Zhao,Jian Liang,Ya-Xin Shen,Ziqi Li,Ben Liu,Jianhai Chen,Wenxiang Cheng,Xueling Bai,Peng Zhang,Qian Liu,Bing Song,Chun Hu,Lichu Liu,Yan Wang +16 more
TL;DR: Astragaloside IV (ASN IV), the predominate phytochemical in Astragalus membranaceus, has been identified as a novel CXCR4 antagonist as mentioned in this paper .
15
Iteratively Reweighte Least Squares Method for Estimating Polyserial and Polychoric Correlation Coefficients
Peng Zhang,Ben Liu,Jingjing Pan +2 more
- 20 Oct 2022
TL;DR: In this article , an iteratively reweighted least squares (IRLS) method is proposed for estimating polyserial and polychoric correlation coefficients, which iteratively calculates the slopes in a series of weighted linear regression models based on conditional expected values.
Shang-Ke-Huang-Shui and coptisine alleviate osteoarthritis in the knee of monosodium iodoacetate-induced rats through inhibiting CXCR4 signaling.
Kuang Tsuong Yang,Qian Xie,Na Zhao,Jian Liang,Ben Liu,Jianhai Chen,Wenxiang Cheng,Xueling Bai,Feng Zhang,Qian Li,Bing Song,Junyi Wang,Fanghao Zheng,Chun Hu,Lichu Liu,Yan Wang +15 more
TL;DR: Wang et al. as mentioned in this paper showed that the traditional Chinese medicine formula SKHS and its predominate phytochemical coptisine significantly alleviated cartilage degradation as well as subchondral bone damage through inhibiting CXCR4-mediated ADAMTS4,5 overexpression.